Advertisement

PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 31–31 | Cite as

Rivaroxaban cost-effective option for DVT/PE in Greece

Clinical study
  • 11 Downloads

Reference

  1. Gourzoulidis G, et al. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece. Clinical Drug Investigation : 12 Jun 2017. Available from: URL: http://doi.org/10.1007/s40261-017-0540-1

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations